Daiken Medical Co., Ltd. (7775.T)
JPY 479.0
(-0.62%)
JPY 479.0
(-0.62%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 1.44 Billion JPY | 36.81% |
| 2022 | 1.05 Billion JPY | -8.38% |
| 2021 | 1.15 Billion JPY | 24.93% |
| 2020 | 921.21 Million JPY | -22.87% |
| 2019 | 1.19 Billion JPY | -4.42% |
| 2018 | 1.24 Billion JPY | -17.01% |
| 2017 | 1.5 Billion JPY | -12.01% |
| 2016 | 1.71 Billion JPY | 0.9% |
| 2015 | 1.69 Billion JPY | 4.57% |
| 2014 | 1.62 Billion JPY | 16.69% |
| 2013 | 1.38 Billion JPY | 10.24% |
| 2012 | 1.26 Billion JPY | 24.26% |
| 2011 | 1.01 Billion JPY | 4.13% |
| 2010 | 974.35 Million JPY | 16.63% |
| 2009 | 835.42 Million JPY | 18.11% |
| 2008 | 707.33 Million JPY | 33.79% |
| 2007 | 528.69 Million JPY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 397 Million JPY | 93.46% |
| 2024 Q2 | 439.56 Million JPY | 10.72% |
| 2023 Q4 | 205.2 Million JPY | -58.3% |
| 2023 FY | 1.44 Billion JPY | 36.81% |
| 2023 Q1 | 339.16 Million JPY | 300.4% |
| 2023 Q2 | 406.14 Million JPY | 19.75% |
| 2023 Q3 | 492.12 Million JPY | 21.17% |
| 2022 Q4 | 84.7 Million JPY | -76.78% |
| 2022 Q1 | 288.01 Million JPY | 32.6% |
| 2022 Q2 | 317 Million JPY | 10.07% |
| 2022 FY | 1.05 Billion JPY | -8.38% |
| 2022 Q3 | 364.73 Million JPY | 15.05% |
| 2021 Q3 | 368.33 Million JPY | 16.45% |
| 2021 FY | 1.15 Billion JPY | 24.93% |
| 2021 Q1 | 249.02 Million JPY | 233.55% |
| 2021 Q2 | 316.31 Million JPY | 27.02% |
| 2021 Q4 | 217.2 Million JPY | -41.03% |
| 2020 Q2 | 261.34 Million JPY | 36.76% |
| 2020 Q1 | 191.09 Million JPY | -19.09% |
| 2020 FY | 921.21 Million JPY | -22.87% |
| 2020 Q3 | 394.12 Million JPY | 50.81% |
| 2020 Q4 | 74.65 Million JPY | -81.06% |
| 2019 Q4 | 236.16 Million JPY | -39.9% |
| 2019 Q2 | 255.22 Million JPY | -17.69% |
| 2019 Q3 | 392.95 Million JPY | 53.96% |
| 2019 Q1 | 310.06 Million JPY | 111.19% |
| 2019 FY | 1.19 Billion JPY | -4.42% |
| 2018 Q1 | 349.91 Million JPY | 54.04% |
| 2018 FY | 1.24 Billion JPY | -17.01% |
| 2018 Q4 | 146.81 Million JPY | -63.0% |
| 2018 Q2 | 356.02 Million JPY | 1.75% |
| 2018 Q3 | 396.83 Million JPY | 11.46% |
| 2017 Q1 | 417.81 Million JPY | 16.34% |
| 2017 Q3 | 445.15 Million JPY | 7.1% |
| 2017 FY | 1.5 Billion JPY | -12.01% |
| 2017 Q4 | 227.15 Million JPY | -48.97% |
| 2017 Q2 | 415.63 Million JPY | -0.52% |
| 2016 Q3 | 498.74 Million JPY | 9.35% |
| 2016 Q1 | 397.27 Million JPY | 8.53% |
| 2016 FY | 1.71 Billion JPY | 0.9% |
| 2016 Q4 | 359.12 Million JPY | -27.99% |
| 2016 Q2 | 456.1 Million JPY | 14.81% |
| 2015 Q2 | 418.63 Million JPY | 2.22% |
| 2015 Q4 | 366.03 Million JPY | -27.04% |
| 2015 FY | 1.69 Billion JPY | 4.57% |
| 2015 Q1 | 409.55 Million JPY | 18.2% |
| 2015 Q3 | 501.71 Million JPY | 19.84% |
| 2014 Q3 | 496.43 Million JPY | 17.43% |
| 2014 FY | 1.62 Billion JPY | 16.69% |
| 2014 Q1 | 356.16 Million JPY | 36.58% |
| 2014 Q2 | 422.74 Million JPY | 18.7% |
| 2014 Q4 | 346.47 Million JPY | -30.21% |
| 2013 Q3 | 457.46 Million JPY | 26.41% |
| 2013 Q1 | 309.77 Million JPY | 27.57% |
| 2013 FY | 1.38 Billion JPY | 10.24% |
| 2013 Q4 | 260.76 Million JPY | -43.0% |
| 2013 Q2 | 361.89 Million JPY | 16.82% |
| 2012 Q1 | 247.78 Million JPY | -9.91% |
| 2012 FY | 1.26 Billion JPY | 24.26% |
| 2012 Q4 | 242.83 Million JPY | -44.48% |
| 2012 Q3 | 437.36 Million JPY | 31.43% |
| 2012 Q2 | 332.78 Million JPY | 34.3% |
| 2011 Q2 | 253.2 Million JPY | 39.1% |
| 2011 Q1 | 182.03 Million JPY | -4.45% |
| 2011 FY | 1.01 Billion JPY | 4.13% |
| 2011 Q4 | 275.03 Million JPY | -9.62% |
| 2011 Q3 | 304.31 Million JPY | 20.19% |
| 2010 Q1 | 218.09 Million JPY | 17.14% |
| 2010 Q2 | 257.62 Million JPY | 18.12% |
| 2010 Q3 | 308.12 Million JPY | 19.61% |
| 2010 FY | 974.35 Million JPY | 16.63% |
| 2010 Q4 | 190.5 Million JPY | -38.17% |
| 2009 Q4 | 186.17 Million JPY | -30.05% |
| 2009 Q1 | 181.65 Million JPY | 197.13% |
| 2009 Q3 | 266.16 Million JPY | 32.14% |
| 2009 FY | 835.42 Million JPY | 18.11% |
| 2009 Q2 | 201.42 Million JPY | 10.88% |
| 2008 FY | 707.33 Million JPY | 33.79% |
| 2008 Q3 | 279.1 Million JPY | 0.0% |
| 2008 Q4 | 61.13 Million JPY | -78.1% |
| 2007 FY | 528.69 Million JPY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| JINS HOLDINGS Inc. | 7.83 Billion JPY | 81.592% |
| Medius Holdings Co., Ltd. | 1.31 Billion JPY | -9.781% |
| Ship Healthcare Holdings, Inc. | 24.44 Billion JPY | 94.098% |
| JTEC Corporation | 285.83 Million JPY | -404.706% |
| Hogy Medical Co.,Ltd. | 4.16 Billion JPY | 65.396% |
| Kawamoto Corporation | 410.2 Million JPY | -251.69% |
| Terumo Corporation | 140.09 Billion JPY | 98.97% |
| KAINOS Laboratories, Inc. | 865.21 Million JPY | -66.739% |
| JAPAN EYEWEAR HOLDINGS CO LTD | 3.7 Billion JPY | 61.01% |
| Sysmex Corporation | 78.38 Billion JPY | 98.159% |
| JMS Co.,Ltd. | -268 Million JPY | 638.299% |
| Nakanishi Inc. | 14.26 Billion JPY | 89.887% |
| Mani, Inc. | 8.39 Billion JPY | 82.809% |
| Olympus Corporation | 43.59 Billion JPY | 96.691% |
| HOYA Corporation | 353.8 Billion JPY | 99.592% |
| SEED Co.,Ltd. | 2.05 Billion JPY | 29.632% |
| Asahi Intecc Co., Ltd. | 22.13 Billion JPY | 93.483% |
| Medikit Co.,Ltd. | 4.67 Billion JPY | 69.16% |
| Menicon Co., Ltd. | 8.95 Billion JPY | 83.886% |
| Sincere Co., LTD. | 377 Million JPY | -282.664% |
| Platz Co., Ltd. | 37.48 Million JPY | -3748.174% |
| Paramount Bed Holdings Co., Ltd. | 13.81 Billion JPY | 89.56% |
| Shofu Inc. | 4.7 Billion JPY | 69.364% |
| Shigematsu Works Co., Ltd. | 784.82 Million JPY | -83.816% |
| Nipro Corporation | 22.33 Billion JPY | 93.541% |
| ASO International, Inc. | 546.5 Million JPY | -163.978% |